ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONXX Onyx Pharmaceuticals, Inc. (MM)

124.70
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Onyx Pharmaceuticals, Inc. (MM) NASDAQ:ONXX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 124.70 0 01:00:00

Onyx Pharmaceuticals Announces Second Quarter 2004 Financial Results Webcast and Teleconference

02/08/2004 10:15pm

PR Newswire (US)


Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.
Onyx Pharmaceuticals Announces Second Quarter 2004 Financial Results Webcast and Teleconference RICHMOND, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference discussing its second quarter 2004 financial results on Monday, August 9, 2004, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the second quarter ended June 30, 2004 will be released earlier that day. Interested parties may access a live webcast of the presentation at: http://audioevent.mshow.com/179451 or by dialing 706-679-4614 and using the passcode 9143944. A replay of the presentation will be available on the Onyx website or by dialing 706-645-9291 and using the passcode 9143944 approximately three hours after the teleconference concludes. The replay will be available through September 9, 2004. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julie Wood of Onyx Pharmaceuticals, Inc., +1-510-262-8757 Web site: http://www.onyx-pharm.com/

Copyright

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart